Bone Heath Improved By Everolimus Plus Exemestane In Post-Menopausal Women With Advan
 

Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength and reduces the chances of cancer spreading (metastasising) in the bone...

More...